Immune checkpoint inhibitors for patients with gene-rearranged non-small cell lung cancer

被引:1
|
作者
Uehara, Yuji [1 ,2 ]
Hakozaki, Taiki [1 ,3 ,4 ]
机构
[1] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Thorac Oncol & Resp Med, Tokyo, Japan
[2] Tokyo Med & Dent Univ, Ctr Innovat Canc Treatment, Grad Sch Med & Dent Sci, Dept Precis Canc Med, Tokyo, Japan
[3] Waseda Univ, Fac Sci & Engn, Grad Sch Adv Sci & Engn, Tokyo, Japan
[4] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Thorac Oncol & Resp Med, 3-18-22 Honkomagome, Bunkyo, Tokyo, Japan
关键词
Immune checkpoint inhibitor (ICI); non-small cell lung cancer (NSCLC); gene rearrangement; biomarker; prognosis; OUTCOMES; IMMUNOTHERAPY; MUTATIONS; EFFICACY; BLOCKADE; NSCLC;
D O I
10.21037/tlcr-22-872
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:6 / 10
页数:5
相关论文
共 50 条
  • [1] Immune checkpoint inhibitors in non-small cell lung cancer
    Eberhardt, Wilfried Ernst Erich
    ONKOLOGE, 2017, 23 (10): : 838 - 844
  • [2] Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Herzberg, Benjamin
    Campo, Meghan J.
    Gainor, Justin F.
    ONCOLOGIST, 2017, 22 (01): : 81 - 88
  • [3] Neoadjuvant Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
    Xue, Chongxiang
    Dong, Huijing
    Chen, Ying
    Lu, Xingyu
    Zheng, Shuyue
    Cui, Huijuan
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (06): : 779 - 788
  • [4] Highlights on immune checkpoint inhibitors in non-small cell lung cancer
    Shen, Meng
    Ren, Xiubao
    TUMOR BIOLOGY, 2017, 39 (03)
  • [5] Immune checkpoint inhibitors in advanced non-small cell lung cancer
    Fabre, Elizabeth
    Pecuchet, Nicola
    Cadranel, Jacques
    BULLETIN DU CANCER, 2016, 103 : S138 - S143
  • [6] Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
    Assi, Hazem I.
    Kamphorst, Alice O.
    Moukalled, Nour M.
    Ramalingam, Suresh S.
    CANCER, 2018, 124 (02) : 248 - 261
  • [7] Efficacy of immune checkpoint inhibitors in younger patients with non-small cell lung cancer
    Shinkichi Takamori
    Mototsugu Shimokawa
    Takefumi Komiya
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 13175 - 13184
  • [8] Efficacy of immune checkpoint inhibitors in younger patients with non-small cell lung cancer
    Takamori, Shinkichi
    Shimokawa, Mototsugu
    Komiya, Takefumi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (14) : 13175 - 13184
  • [9] Identification of immune-related gene signature for non-small cell lung cancer patients with immune checkpoint inhibitors
    Wang, Li
    Han, Chaonan
    Cai, Chenlei
    Wu, Jing
    Chen, Jianing
    Su, Chunxia
    HELIYON, 2024, 10 (05)
  • [10] Immune Checkpoint Inhibitors in ROS1-Rearranged Non-Small Cell Lung Cancer: A Report of Two Cases
    Jain, Aditya
    Fujioka, Naomi
    Patel, Manish
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (08) : E165 - E167